Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization is for the use of mRNA-1273 in individuals aged 18 years and more for the prevention of Covid-19 caused by severe acute respiratory syndrome […]
Research Centers of America (RCA), an independent research site in Broward County, Florida, said that it is currently holding COVID-19 vaccine trials, implemented under the US government’s Operation Warp Speed (OWS). The research site is enrolling volunteers to take part in the clinical trials, working with the US government and various pharma companies, which have developed […]
Continue reading …Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former’s mRNA vaccine candidate against COVID-19, at the latter’s facility in Madrid, Spain. Under the agreement terms, ROVI will offer vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic […]
Continue reading …Moderna said that it has concluded enrollment for the two cohorts of the phase 2 study of its COVID-19 vaccine candidate mRNA-1273. According to the US biotech company, mRNA-1273 is its second messenger RNA (mRNA) vaccine for an infectious disease to have wrapped up enrollment of a phase 2 clinical trial, after its CMV Phase 2 […]
Continue reading …Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]
Continue reading …